| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.35B | +17.2% |
| Cost of Revenue | $2.72B | +13.5% |
| Gross Profit | $5.63B | +19.1% |
| R&D Expense | $1.15B | +14.7% |
| SG&A Expense | $2.14B | +9.0% |
| Operating Income | $2.35B | +32.9% |
| Pre-tax Income | $2.67B | +36.5% |
| Income Tax | $336.3M | +137.5% |
| Net Income | $2.32B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.03B | -26.3% |
| Short-term Investments | $1.99B | -19.7% |
| Accounts Receivable | $1.23B | +8.4% |
| Inventory | $1.49B | +21.8% |
| Current Assets | $7.11B | -9.9% |
| Total Assets | $18.74B | +21.4% |
| Current Liabilities | $1.75B | +5.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.42B | +33.1% |
| Investing Cash Flow | -$3.27B | -808.9% |
| Financing Cash Flow | $150.9M | +152.5% |
| +29.2% |
| EPS (Basic) | $6.54 | +27.7% |
| EPS (Diluted) | $6.42 | +27.6% |
| Total Liabilities |
| $2.21B |
| +8.3% |
| Stockholders' Equity | $16.43B | +23.5% |